Formulary Chapter 6: Endocrine system - Full Chapter
|
06.01.02.03 |
Other antidiabetic drugs |
|
|
06.01.02.03 |
Alpha glucosidase inhibitors |
|
|
06.01.02.03 |
DPP-4 inhibitors ('gliptins) |
|
|
06.01.02.03 |
GLP-1 agonists/analogues |
|
|
06.01.02.03 |
SGLT-2 inhibitors ('gliflozins) |
|
|
06.01.02.03 |
Thiazolidinediones |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Traffic Light Status Information
Status |
Description |

|
Suitable for prescribing by all in both primary and secondary care. |

|
Specialist recommended but suitable for continuation in primary care. |

|
Specialist initiated but suitable for continuation in primary care. |

|
Specialist initiated and for continuation in primary care under a locally approved shared care guideline. |

|
Suitable for prescribing in specialist settings (secondary care) only. |

|
Secondary care medicines to be used under specialised commissioning arrangements only. |

|
For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital
pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy. |

|
Not recommended for use. |
|
|